Authors: AN ZL WANG XE WILLMOTT N CHANDER SK TICKLE S DOCHERTY AJP MOUNTAIN A MILLICAN AT MORPHY R PORTER JR EPEMOLU RO KUBOTA T MOOSSA AR HOFFMAN RM

Citation: Zl. An et al., CONVERSION OF HIGHLY MALIGNANT COLON-CANCER FROM AN AGGRESSIVE TO A CONTROLLED DISEASE BY ORAL-ADMINISTRATION OF A METALLOPROTEINASE INHIBITOR, Clinical & experimental metastasis, 15(2), 1997, pp. 184-195

Authors: CHOUDHURY R EPEMOLU RO RAI BL HIDER RC SINGH S

Citation: R. Choudhury et al., METABOLISM AND PHARMACOKINETICS OF METHYLACETOXYETHYL)-2-ETHYL-3-HYDROXYPYRIDIN-4-ONE (CP117) IN THE RAT, Drug metabolism and disposition, 25(3), 1997, pp. 332-339

Authors: SINGH S CHOUDHURY R EPEMOLU RO HIDER RC

Citation: S. Singh et al., METABOLISM AND PHARMACOKINETICS OF 1-(2'-HYDROXYETHYL)-2-ETHYL-3-HYDROXYPYRIDIN-4-ONE AND -(3'-HYDROXYPROPYL)-2-ETHYL-3-HYDROXYPYRIDIN-4-ONE IN THE RAT, European journal of drug metabolism and pharmacokinetics, 21(1), 1996, pp. 33-41

Authors: EPEMOLU RO ACKERMAN R PORTER JB HIDER RC DAMANI LA SINGH S

Citation: Ro. Epemolu et al., HPLC DETERMINATION OF 1,2-DIETHYL-3-HYDROXYPYRIDIN-4-ONE (CP94), ITS IRON COMPLEX [FE(III) (CP94)3] AND GLUCURONIDE CONJUGATE [CP94-GLUC] IN SERUM AND URINE OF THALASSEMIC PATIENTS, Journal of pharmaceutical and biomedical analysis, 12(7), 1994, pp. 923-930